![Hardy Kagimoto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hardy Kagimoto
Fondatore presso
HEALIOS K.K.
Patrimonio netto: 174 M $ in data 31/07/2026
Profilo
Hardy T.
S.
Kagimoto was the founder of PowerX, Inc. (founded in 2021) serving as Chairman; Healios KK (founded in 2011) serving as President, CEO & Representative Director; and Aqumen Biopharmaceuticals KK (founded in 2005) serving as Chairman, President & Chief Executive Officer.
Current jobs include President & Representative Director at Kagimoto Holdings KK since 2011, Adviser at Saisei Ventures LLC, and President at Sighregen Co., Ltd. since 2014.
Former jobs include President & Director at Healios N.A., Inc. and Director at Athersys, Inc. from 2018 to 2022.
Education includes a doctorate from Kyushu University conferred in 2002.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
POWERX, INC. 11,65% | 21/01/2026 | 13.368.000 ( 11,65% ) | 132 M $ | 31/07/2026 |
HEALIOS KK 20,61% | 31/12/2025 | 27.830.300 ( 20,61% ) | 41 M $ | 31/07/2026 |
Posizioni attive di Hardy Kagimoto
| Società | Posizione | Inizio |
|---|---|---|
| HEALIOS K.K. | Fondatore | 24/02/2011 |
| POWERX,INC. | Fondatore | 22/03/2021 |
Kagimoto Holdings KK | Presidente | 01/11/2011 |
Sighregen Co., Ltd. | Presidente | 01/02/2014 |
Saisei Ventures LLC
 Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Consulente / Consigliere | - |
Precedenti posizioni note di Hardy Kagimoto
| Società | Posizione | Fine |
|---|---|---|
| ATHERSYS, INC. | Direttore/Membro del Consiglio | 16/06/2022 |
Healios N.A., Inc. | Presidente | - |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Amministratore Delegato | - |
Formazione di Hardy Kagimoto
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
49
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Kyushu University
 Kyushu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Healios KK
 Healios KK Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of cell therapy and regenerative medicine products | Health Technology |
Kagimoto Holdings KK | |
Sighregen Co., Ltd. | |
Healios N.A., Inc. | |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures invests in companies located across the globe. The firm focuses on the biotechnology sector with a focus on advanced therapies such as cell and gene therapies and regenerative medicines. It participates in seed and early stage transactions. | Finance |
PowerX, Inc.
 PowerX, Inc. Electrical ProductsProducer Manufacturing Manufactures and sells batter energy storage systems & operates EV charging stations and provides power supply services | Producer Manufacturing |
